Socioeconomic disparity in cardiovascular disease: Possible biological pathways based on a proteomic approach

Bilal Hasan Shafi1, Morten Bøttcher2, Ali Ejupi1

  • 1Department of Cardiology, Bispebjerg University Hospital, Copenhagen, Denmark.

Atherosclerosis
|June 12, 2022
PubMed

Insights

Socioeconomic disparities in cardiovascular disease (CVD) are linked to biological pathways. Inflammation, platelet activation, and blood pressure biomarkers may explain these differences, highlighting potential targets for intervention.

Area of Science:

  • Biomedical research
  • Cardiovascular disease epidemiology
  • Biomarker discovery

Background:

  • Significant social disparities exist in cardiovascular disease (CVD) occurrence.
  • Underlying biological mechanisms driving these disparities remain largely unknown.

Purpose of the Study:

  • To investigate biomarkers linked to CVD to understand socioeconomic disparities.
  • To quantify biological pathways mediating socioeconomic differences in CVD through risk factors.

Main Methods:

  • Analysis of 184 biomarkers in 1142 participants (aged 55-64) from the Copenhagen City Heart Study.
  • Socioeconomic position (SEP) defined by education length and household income.
  • Statistical analysis including Pearson's correlation and multivariate-adjusted linear regression.

Main Results:

  • 48 biomarkers significantly correlated with education length; strongest associations with interleukin-6 (IL-6), GDF-15, RARRES2, leptin (LEP), vWF, and renin (REN).
  • 14 biomarkers remained significantly associated with education after multivariate adjustment.
  • Proportion mediated by CVD risk factors varied from <1% to 100%.

Conclusions:

  • Socioeconomic position is associated with multiple biomarkers, suggesting pathways involving inflammation, platelet activation, blood pressure, and MAPK cascade.
  • These pathways may contribute to socioeconomic differences observed in CVD.
  • Identified biomarkers offer potential targets for understanding and mitigating CVD disparities.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
331
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
798
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
290